Treating Hyperkalemic Periodic Paralysis
治疗高钾性周期性麻痹
基本信息
- 批准号:10537584
- 负责人:
- 金额:$ 4.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:Action PotentialsAddressCalciumClinicalClinical ResearchClinical TrialsCognition DisordersCollaborationsComplexConotoxinCouplingDataDiseaseDisease modelElectrophysiology (science)EventFDA approvedFailureFamilyFiberFutureGenerationsGenesGoalsHyperkalemic periodic paralysisInfusion proceduresInheritedIonsKnowledgeMeasurementMeasuresMembrane PotentialsModelingMolecular ConformationMusMuscleMuscle FibersMuscular AtrophyMutationMyopathyNappingPainParalysedPathologicPatientsPharmaceutical PreparationsPublic HealthResearch DesignRoleSeriesSkeletal MuscleSodium ChannelSpecificityStudy modelsTechniquesTestingTranslatingWild Type MouseWorkchannel blockerseffective therapyexperienceexperimental studygain of function mutationmouse modelmutantnovelnovel strategiesnovel therapeuticspreventside effecttherapy developmentvoltage clamp
项目摘要
Project Summary/Abstract
Hyperkalemic Periodic Paralysis (HyperKPP) is one of a family of inherited skeletal muscle diseases known as
the ion channelopathies. HyperKPP patients have mutations in the skeletal muscle Nav1.4 sodium channel.
Importantly, patients suffer intermittent attacks of muscle paralysis and weakness lasting from minutes to days.
Despite identification of the gene responsible, mechanisms underlying the attacks of weakness remain poorly
understood, and current therapies are only modestly effective and have side effects. A mouse model of
HyperKPP has been generated, which recapitulates the key aspects of the disorder in patients. The mouse
model will be used to identify mechanisms contributing to failure of excitation contraction coupling caused by
pathologic depolarization of the membrane potential. These correlated studies will range from ex vivo whole-
muscle force recordings down to measurement of Ca transients in single fibers. A new technique allows for
simultaneous, intracellular recordings of action potentials and Ca transients of single muscle fibers in an intact
muscle. The overall goal is to address currently poorly understood aspects of HyperKPP and to develop novel
strategies for better therapies. This will be done in three Specific Aims:
1) Determine the mechanisms underlying depolarization-induced failure of excitation contraction
coupling (ECC) in normal muscle: Pilot data suggests failure of ECC is more complex than previously
suspected. The proposed correlated studies will elucidate the events preceding failure of ECC.
2) Determine the extent to which depolarization of the membrane potential contributes to failure of ECC
in HyperPP. The proposed studies will determine whether excessive depolarization of mutant muscle can fully
account for weakness. A series of electrophysiology experiments in HyperKPP vs. wild-type mice will address
this fundamental question.
3) Examine block of depolarizing current with a more selective blocker as an effective therapy for
HyperKPP. If the primary cause of HyperKPP is muscle depolarization, blocking the depolarizing current
should provide effective therapy. However, clinical studies suggest that the current Na channel blockers are
not effective in patients.
Identification of mechanisms contributing to depolarization-induced weakness in HyperKPP has implications for
all diseases in which depolarization of muscle contributes to weakness. If effective therapies are found to treat
weakness in the mouse model of HyperkPP, future work will be directed at translating findings to clinical trials
in patients.
项目摘要/摘要
高钾性周期性麻痹(HyperKPP)是一种遗传性骨骼肌疾病家族,被称为
离子通道病。HyperKPP患者骨骼肌Nav1.4钠通道发生突变。
重要的是,患者会间歇性发作肌肉瘫痪和虚弱,持续时间从几分钟到几天不等。
尽管确定了导致虚弱发作的基因,但其潜在的机制仍然很差。
了解,目前的治疗方法只有一定的效果,而且有副作用。一种小鼠模型
已经生成了HyperKPP,它概括了患者疾病的关键方面。鼠标
模型将被用来确定导致激励收缩耦合失败的机制
病理性的膜电位去极化。这些相关研究的范围将从体外整体-
肌力记录可以精确到测量单个纤维中的钙瞬变。一种新技术允许
单根肌纤维动作电位和钙瞬变的细胞内同步记录
肌肉。总体目标是解决目前对HyperKPP知之甚少的方面,并开发新的
更好的治疗策略。这项工作将有三个具体目标:
1)确定去极化导致兴奋收缩失败的机制
正常肌肉中的偶联(ECC):试点数据表明ECC的故障比以前更复杂
有嫌疑。拟议的相关研究将阐明ECC失败之前的事件。
2)确定膜电位的去极化对ECC失效的影响程度
在HyperPP中。拟议中的研究将确定突变肌肉的过度去极化是否能完全
解释软弱的原因。HyperKPP与野生型小鼠的一系列电生理学实验将解决
这个根本性的问题。
3)使用更具选择性的阻滞剂检查去极化电流的阻断,作为治疗的有效方法
HyperKPP。如果HyperKPP的主要原因是肌肉去极化,那么阻断去极化电流
应该能提供有效的治疗。然而,临床研究表明,目前的钠通道阻滞剂是
对病人无效。
识别导致HyperKPP去极化诱导的弱的机制具有以下意义
肌肉去极化导致虚弱的所有疾病。如果找到有效的治疗方法
在HyperkPP小鼠模型的弱点下,未来的工作将致力于将发现转化为临床试验
在病人身上。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher Dupont其他文献
Christopher Dupont的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher Dupont', 18)}}的其他基金
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 4.41万 - 项目类别:
Research Grant